Ignite Creation Date:
2024-05-06 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06015737
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2023-08-01
Brief Title:
A 2-stage Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic andor Subacute Cutaneous Lupus Erythematosus
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Cutaneous Lupus Erythematosus |